Home > Healthcare > Medical Devices > Therapeutic Devices > Wearable Injectors Market

Wearable Injectors Market Share

Report ID: GMI5891
Published Date: May 2023
Report Format: PDF

Download Free Sample

Major Wearable Injectors Market Share

The top players involved in the wearable injectors industry report are

Amgen Inc.
United Therapeutics, Inc.
Insulet Corporation
West Pharmaceutical Services, Inc.
Medtronic, Plc.
Tandem Diabetes Care
Enable Injections
Ypsomed
CeQur SA
Subcuject
Eitan Medical

These companies are engaging in strategic partnerships and mergers, along with new product launches, to stay ahead in the industry.

Authors: Mariam Faizullabhoy , Subodh Kharad

Frequently Asked Questions (FAQ) :

Global market for wearable injectors was worth USD 8 billion in 2022 and will progress at more than 13.5% CAGR between 2023 and 2032 propelled by the growing prevalence of chronic diseases, including immunological disorders, diabetes, cardiovascular diseases, and cancer, among others.

The on-body segment is poised to reach more than USD 15 billion in revenue by 2032 as a result of continuous improvements in wearable injector design, specs, and technology that offer ergonomic design, compact device, and water resistance advantages.

The diabetes application segment will be valued at USD 9 billion by 2032 owing to the positive inclination of healthcare professionals owing to numerous advantages for managing diabetes.

North America wearable injectors market is slated to grow at more than 13.5% CAGR over 2023-2032 on account of the high prevalence of diabetes and advanced healthcare infrastructure in the region.